Malignancy in the HIV-infected patients undergoing liver and kidney transplantation
- 1 September 2012
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Oncology
- Vol. 24 (5), 517-521
- https://doi.org/10.1097/cco.0b013e328355e0d7
Abstract
Purpose of review The transplant community has seen the gradual acceptance of liver and kidney transplantation in carefully selected HIV-positive patients. The addition of transplant immunosuppressants to an already immunocompromised state, however, may increase the risk of malignancy. Recent findings Kidney transplantation and liver transplantation have been successful in large series of carefully selected HIV-infected patients, with graft and patient survival approaching those of non-HIV-infected patients. The incidence of acute cellular rejection (kidney transplantation) and of recurrent hepatitis C (liver transplantation) remains challenging. Hepatocellular carcinoma (HCC), which is a common indication for liver transplantation, seems to occur at a younger age and to have a generally worse outcome in the HIV-positive patients. Liver transplantation outcomes for HCC in these patients, however, do not seem to be compromised. Rates of Kaposi's sarcoma and other de-novo malignancies such as skin cancer are relatively low after transplant. Kaposi's sarcoma may regress with the use of the mammalian target of rapamycin inhibitor sirolimus. In HIV-positive patients followed closely for human papilloma virus (HPV)-related anal neoplasia after transplantation, there may be an increased risk of progression to high-grade squamous intraepithelial lesions. Summary The risk of recurrent or de-novo malignancy after solid-organ transplantation in HIV patients is low. HPV-related neoplasia, however, requires further study.Keywords
This publication has 14 references indexed in Scilit:
- Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectionLiver Transplantation, 2012
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Hepatocellular Carcinoma in HIV-Infected Patients: Check Early, Treat HardThe Oncologist, 2011
- Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohortAIDS, 2011
- Outcomes of Kidney Transplantation in HIV-Infected RecipientsThe New England Journal of Medicine, 2010
- Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infectionJournal of Hepatology, 2010
- HBV and HIV Coinfection and Liver TransplantAmerican Journal of Transplantation, 2010
- Kaposi’s sarcoma after liver transplantationZeitschrift für Krebsforschung und Klinische Onkologie, 2007
- Sirolimus for Kaposi's Sarcoma in Renal-Transplant RecipientsThe New England Journal of Medicine, 2005
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisThe New England Journal of Medicine, 1996